首页 › 基金 › SB INVESTMENT ADVISERS (UK) LTD › VIR

SB INVESTMENT ADVISERS (UK) LTD 对 VIR 的持仓历史

VIR BIOTECHNOLOGY INC · 医疗保健

SB INVESTMENT ADVISERS (UK) LTD 在 Q3 2026 的 13F 申报中披露持有 VIR(VIR BIOTECHNOLOGY INC)10,948,093 股,市值约 US$122.4M,约占其申报组合的 1.99%,在其申报持仓中市值排名第 5 位。 SB INVESTMENT ADVISERS (UK) LTD 最近 13 个申报季度中有 13 个季度披露了 VIR 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)10.95M 股
申报持仓市值$122.40M
组合权重1.99%
首次申报Q3 2023
最近变动持有
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

SB INVESTMENT ADVISERS (UK) LTD 对 VIR 的持仓演变

SB INVESTMENT ADVISERS (UK) LTD 于 Q3 2023 首次披露 VIR 持仓:16,684,041 股(约 US$156.3M)。 该持仓在 Q1 2024 达到峰值 16,684,041 股,市值约 US$169.0M。 在 13 次申报中,SB INVESTMENT ADVISERS (UK) LTD 0 次增持、2 次减持、10 次保持不变。 最近一期申报(Q3 2026)显示持股 10,948,093 股、市值约 US$122.4M。

逐季持仓明细

季度股数金额变化
Q3 2023 16.68M $156.33M 新进
Q4 2023 16.68M $167.84M 持有
Q1 2024 16.68M $169.01M 持有
Q2 2024 16.68M $148.49M 持有
Q3 2024 16.68M $124.96M 持有
Q4 2024 16.68M $122.46M 持有
Q1 2025 16.68M $108.11M 持有
Q2 2025 16.68M $84.09M 持有
Q3 2025 16.68M $95.27M 持有
Q4 2025 13.12M $79.10M 减持
Q1 2026 10.95M $98.09M 减持
Q2 2026 10.95M $111.56M 持有
Q3 2026 10.95M $122.40M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 VIR 与 13F 数据

VIR(VIR BIOTECHNOLOGY INC)属于医疗保健行业。我们追踪的基金中还有 37 只申报持有 VIR,申报仓位最大的包括:ARCH Venture Management, LLC (US$141.9M), GSK plc (US$95.6M), MPM BioImpact LLC (US$31.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 VIR 的基金

查看 VIR 的全部基金持有人 →

常见问题

How long has SB INVESTMENT ADVISERS (UK) LTD held VIR?

SB INVESTMENT ADVISERS (UK) LTD has disclosed VIR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SB INVESTMENT ADVISERS (UK) LTD's current position in VIR?

As of Q3 2026, SB INVESTMENT ADVISERS (UK) LTD holds 10.95M shares of VIR (VIR BIOTECHNOLOGY INC), valued at $122.40M, representing 1.99% of its reported portfolio and ranking #5.

Has SB INVESTMENT ADVISERS (UK) LTD been buying or selling VIR?

In the latest 13F filing (Q3 2026), SB INVESTMENT ADVISERS (UK) LTD held unchanged its position in VIR. The position peaked in Q1 2024 at 16.68M shares.

Which other funds hold VIR?

Other major institutional holders of VIR include ARCH Venture Management, LLC, GSK plc, MPM BioImpact LLC, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.